Pages that link to "Q73536158"

The following pages link to Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro (Q73536158):

Displaying 44 items.

• RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition (Q24316899) (← links)
• Estrogen activates cyclin-dependent kinases 4 and 6 through induction of cyclin D in rat primary osteoblasts (Q28579459) (← links)
• Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. (Q30438632) (← links)
• Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells (Q33182174) (← links)
• Cyclins and breast cancer (Q33538420) (← links)
• 9-Cis-retinoic acid induces growth inhibition in retinoid-sensitive breast cancer and sea urchin embryonic cells via retinoid X receptor α and replication factor C3 (Q33636273) (← links)
• Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms (Q33672257) (← links)
• Role of retinoid receptors in the prevention and treatment of breast cancer (Q33856014) (← links)
• Retinoids and ovarian cancer (Q34002981) (← links)
• Discovering transcription factor regulatory targets using gene expression and binding data (Q34074703) (← links)
• Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment (Q34106787) (← links)
• Retinoid mechanisms and cyclins (Q34272008) (← links)
• Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes (Q34515989) (← links)
• During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein. (Q35029586) (← links)
• Vitamin A and infancy. Biochemical, functional, and clinical aspects (Q35173888) (← links)
• Cyclin D1 as a target for chemoprevention (Q35179461) (← links)
• Genotoxic and oxidative damage potentials in human lymphocytes after exposure to terpinolene in vitro (Q35211507) (← links)
• Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteins (Q35238042) (← links)
• Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget (Q35273449) (← links)
• A Novel Knowledge-Driven Systems Biology Approach for Phenotype Prediction upon Genetic Intervention (Q35536232) (← links)
• Small-molecule cyclin-dependent kinase modulators (Q35551149) (← links)
• Role of traditional and new biomarkers in breast carcinogenesis. (Q35572905) (← links)
• Retinoic acid-induced cell cycle arrest of human myeloid cell lines. (Q35614617) (← links)
• Role of retinoid signaling in the regulation of spermatogenesis (Q35827756) (← links)
• Metabolism and regulation of gene expression by 4-oxoretinol versus all-trans retinoic acid in normal human mammary epithelial cells (Q35860799) (← links)
• Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. (Q36028691) (← links)
• The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells (Q36732254) (← links)
• Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line (Q37231460) (← links)
• Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells (Q37384426) (← links)
• Syntheses, antiproliferative activity and theoretical characterization of acitretin-type retinoids with changes in the lipophilic part (Q39611872) (← links)
• Differential regulation of protein expression, growth and apoptosis by natural and synthetic retinoids (Q40621336) (← links)
• Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway (Q40643851) (← links)
• The modified firefly luciferase reporter gene (luc ) but not Renilla luciferase is induced by all-trans retinoic acid in MCF-7 breast cancer cells (Q40667319) (← links)
• The anti-estrogenic effect of all-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on HES-1 expression (Q40722919) (← links)
• The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest (Q40761333) (← links)
• Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity (Q40888652) (← links)
• The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells (Q42446700) (← links)
• Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells (Q42538869) (← links)
• Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression (Q43831014) (← links)
• Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells (Q43955953) (← links)
• A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels (Q44413732) (← links)
• Can breast cancer be chemoprevented in 2003? (Q44487660) (← links)
• Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. (Q51240694) (← links)
• Prevention of breast cancer (Q73733419) (← links)